STIM
:Neuronetics Inc
Snapshot
|
Charting
|
News
|
Options
$2.52
3.70%
$0.09
NASDAQ
7:32a ET
May 15 '24
Humana Is First Commercial Payer to Address TMS Therapy Coverage for Adolescents
GlobeNewswire
Last
Change
Exchange
Market data is delayed by at least 15 minutes.
Markets
Portfolio
Symbol Lookup
Latest Story
Top Stories on STIM
No News Available
Neuronetics Reports Record First Quarter 2024 Financial and Operating...
7:30a ET May 7 '24
GlobeNewswire
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c...
4:30p ET May 3 '24
GlobeNewswire
NeuroStar(R) TMS Advances Treatment for Adolescents During Mental Hea...
8:31a ET May 1 '24
GlobeNewswire
Neuronetics to Report First Quarter 2024 Financial and Operating Resu...
4:30p ET April 23 '24
GlobeNewswire
New Publication in Brain Stimulation Confirms Full TMS Treatment Cour...
8:31a ET April 10 '24
GlobeNewswire
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c...
4:30p ET March 27 '24
GlobeNewswire
NeuroStar(R) Advanced Therapy Receives FDA Clearance as a First-Line ...
8:30a ET March 25 '24
GlobeNewswire
Neuronetics Announces 5-Year Exclusive Partnership with Transformatio...
8:22a ET March 7 '24
GlobeNewswire
Neuronetics Reports Record Fourth Quarter and Record Full Year 2023 F...
7:30a ET March 5 '24
GlobeNewswire
Neuronetics to Report Fourth Quarter 2023 Financial and Operating Res...
8:30a ET February 20 '24
GlobeNewswire
Market data provided by
News provided by